Access to medicinal cannabis for patients to be simplified
|

Access to medicinal cannabis for patients to be simplified

Access to medicinal cannabis for patients to be simplified Bern, 22.06.2022 – The Federal Council wants to make it easier for patients to access medicinal cannabis. It therefore decided at its meeting on June 22 to lift the ban on cannabis for medicinal purposes from the Narcotics Act. Medical prescriptions no longer require an exceptional…

Therapeutical potential of CBD for skin health

Therapeutical potential of CBD for skin health

Cannabidiol (CBD) a non-psychoactive compound from the cannabis plant have been shown to have a positive effect against many dermatological disorders such as eczema, psoriasis, pruritis, and inflammatory conditions.   One of the important systems in our body is the Endocannabinoid System (ECS). It plays the role of molecular signaling network, important for the modulation of…

Medical Cannabis for the Treatment of Fibromyalgia
|

Medical Cannabis for the Treatment of Fibromyalgia

Fibromyalgia is a chronic pain syndrome, often accompanied be sleeping disturbances, chronic musculoskeletal pain, fatigue, and mood disturbances. The pathogenesis of fibromyalgia is not clear. It usually affects women more than men and has a genetic preponderance. Fibromyalgia can have physical and psychological, impacts on patients. Unfortunately, in most patients, fibromyalgia is chronic. Usual medications…

Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline

Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline

clinical practice guideline; this article published in the british medical journal, summarizes the current state of medical research about chronic pain. Abstract Clinical question What is the role of medical cannabis or cannabinoids for people living with chronic pain due to cancer or non-cancer causes? Current practice Chronic pain is common and distressing and associated with considerable…

Medical cannabis for psychiatric disorders

Medical cannabis for psychiatric disorders

Over last few years researchers’ attention has been focused on use of medical cannabis due to global regulatory loosening. This fact significantly increased cannabinoid therapeutics analytical data in psychiatric field. Many of them suggest that cannabinoid might improve depressive disorders and symptoms, anxiety disorders, attention-deficit hyperactivity disorder, Tourette syndrome, post-traumatic stress disorder, or psychosis. Moreover,…

Cannabis – from hippie drug to medical hype (SRF, 25.04.2022)
| | | |

Cannabis – from hippie drug to medical hype (SRF, 25.04.2022)

The SRF documentary on Medical Cannabis provides an overview on the current market situation Key takeouts: good results on patients using the medicine high prices for patient due to 1 company dominant position flowers are not yet available as medicine (it will only be available with the #pilotprojects medical Cannabis still need to evolve from…

Cannabinoids in the Treatment of Epilepsy
|

Cannabinoids in the Treatment of Epilepsy

Epilepsy is one of the most common non-transmissible neurological diseases. It is defined as a brain disorder that predisposes to seizures and has associated physical, psychological and social consequences. Approximately one-third of patients with epilepsy have seizures that are resistant to antiepileptic medications. These patients do not respond well to the conventional antiepileptic drugs. Moreover,…

Analysis of the General decision of the Swiss Chemicals Notification Authority concerning the placing on the market of perfume oil containing CBD

Analysis of the General decision of the Swiss Chemicals Notification Authority concerning the placing on the market of perfume oil containing CBD

March 24th 2022 – General decision of the Swiss Chemicals Notification Authority concerning the placing on the market of fragrances / perfume oil containing CBD, pursuant to Art. 10 (1) and (2) in connection with Art. 1 (1) to (3) of the Pest Control Products Act. A Federal decision on banning CBD from fragrances (chemical…

Medical cannabis available by prescription
|

Medical cannabis available by prescription

Starting this summer, it will be easier to get a prescription for medical cannabis. But watch your wallet, because it won’t be automatically reimbursed. Cannabis-based medicines will soon be available by prescription, without the need for exceptional authorization from the Federal Office of Public Health (FOPH). This legislative change will probably come into force in…

Analysis of the Swiss chemists’ statement saying most CBD cannabis products fail to meet standards. However, it only concerns food and veterinary products.
| |

Analysis of the Swiss chemists’ statement saying most CBD cannabis products fail to meet standards. However, it only concerns food and veterinary products.

On February 1st 2022, the Swiss Association of Cantonal Chemists, announced in a press release that, in Switzerland, the vast majority of products sold containing the cannabis extract cannabidiol (CBD) do not meet legal requirements. It was relayed across many media channels, such as swissinfo stating that Most CBD cannabis products fail to meet standards. However, these findings do not apply to the medical/therapeutic cannabis.